Five or seven days after transplantation, we found that these injected monocytes expressed substantial levels of both Trem2 as well as the tumor-specific SCAM marker, Vcam1, compared to the monocytes before injection (Fig. 8m, n). The gene discussed is TREM2; the disease is neoplasm.